Search
for
Sort by
Research 301–330 of 1000+
- Emotional burden and current management practices in pediatric alopecia areata: An online survey among physicians
- Recent trends in nanocarrier formulations of actives beyond minoxidil and 5-α reductase inhibitors in androgenetic alopecia management: A systematic review
- A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy
- Aim to alleviate alopecia areata with newly available agents
- Research Progress of Extracellular Vesicles-Loaded Microneedle Technology
- Homoeopathic intervention in classic case of alopecia areata: A case study
- Understanding Alopecia Areata: Types, Causes, and Latest Therapeutic Approaches
- Nanotechnology-Based Strategies for Hair Follicle Regeneration in Androgenetic Alopecia
- 551 Combining Laser Capture Microdissection and RNAseq Analysis to Generate a Human Anagen Hair Follicle Transcriptome Atlas
- 305 Overlaps between inflammatory dermatoses and ichthyoses: need for novel therapeutic approaches
- 067 BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases
- A Review on Nanoparticle Based Herbal Remedies for the Management of Alopecia
- 034 Characterization of novel TMEM173 mutation causing a lupus- and SAVI-like phenotype, modified by polymorphisms in TMEM173 and IFIH1
- 526 Gut dysbiosis in alopecia areata patients reveals overabundance of firmicutes and under representation of bacteroides
- Hair Changes due to Drugs
- Alopecia areata - current trends in treatment
- Hair and nail adverse events during treatment with target therapies for metastatic melanoma
- Hair Disorders Associated with Anticancer Agents
- Symposium Proceedings of the 4th Intercontinental Meeting of Hair Research Societies: “The World of Hair 2004”
- THE ROLE OF AGONISTS AND ANTAGONISTS OF THE WNT SIGNALING PATHWAY IN PATIENTS WITH ANDROGENIC ALOPECIA AND ALOPECIA AREATA
- The role of androgens in COVID-19
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Endocrinology of the Aging Prostate: Current Concepts
- The epidermal growth factor receptor decreases Stathmin 1 and triggers catagen entry in the mouse
- Lipid-based nanoformulation optimization for achieving cutaneous targeting: Niosomes as the potential candidates to fulfill this aim
- Mediator1: An Important Intermediary of Vitamin D Receptor–Regulated Epidermal Function and Hair Follicle Biology
- Bioabsorbable nano-micelle hybridized hydrogel scaffold prevents postoperative melanoma recurrence
- Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review